SAB BIOTHERAPEUTICS INC's ticker is and the CUSIP is 78397T111. A total of 16 filers reported holding SAB BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,426 | -32.9% | 148,939 | 0.0% | 0.00% | – |
| Q2 2023 | $15,549 | +190.0% | 148,939 | 0.0% | 0.00% | – |
| Q1 2023 | $5,362 | -23.4% | 148,939 | 0.0% | 0.00% | – |
| Q4 2022 | $7,001 | -22.2% | 148,939 | 0.0% | 0.00% | – |
| Q3 2022 | $9,000 | -59.1% | 148,939 | 0.0% | 0.00% | – |
| Q2 2022 | $22,000 | -69.4% | 148,939 | -1.3% | 0.00% | – |
| Q1 2022 | $72,000 | +28.6% | 150,846 | +380.3% | 0.00% | – |
| Q4 2021 | $56,000 | – | 31,407 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LMR Partners LLP | 358,349 | $520,000 | 0.01% |
| Shaolin Capital Management LLC | 823,999 | $156,000 | 0.00% |
| Yakira Capital Management, Inc. | 108,485 | $17,000 | 0.00% |
| Radcliffe Capital Management, L.P. | 55,692 | $81,000 | 0.00% |
| EQUITEC PROPRIETARY MARKETS, LLC | 45,000 | $7,000 | 0.00% |
| MARSHALL WACE, LLP | 285,000 | $413,000 | 0.00% |
| MORGAN STANLEY | 148,939 | $22,000 | 0.00% |
| Walleye Trading LLC | 15,505 | $2,000 | 0.00% |
| Citadel Advisors | 18,711 | $3,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 10,944 | $2,000 | 0.00% |